Your browser doesn't support javascript.
loading
A new derivatization reagent for LC-MS/MS screening of potential genotoxic alkylation compounds.
van Wijk, A M; Niederländer, H A G; Siebum, A H G; Vervaart, M A T; de Jong, G J.
Afiliación
  • van Wijk AM; Abbott Healthcare Products BV, Manufacturing, Science and Technology, Established Pharmaceuticals, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands.
J Pharm Biomed Anal ; 74: 133-40, 2013 Feb 23.
Article en En | MEDLINE | ID: mdl-23245244
A screening method for trace analysis of potentially genotoxic alkylating compounds has been developed using butyl 1-(pyridin-4-yl) piperidine 4-carboxylate (BPPC) as a new, selective pre-column derivatization reagent for their subsequent analysis by hydrophilic interaction liquid chromatography (HILIC) hyphenated with tandem mass spectrometry (LC-MS/MS). The new derivatization reagent is a modification of 4-dimethylaminopyridine (4-DMAP) previously used for the determination of potentially genotoxic compounds. By using the new reagent the screening potential was enhanced without compromising reactivity. Derivatization at a high pH value was carried out and the reaction time at 60°C was 24h to anticipate for alkyl chlorides showing to be less reactive. The new reagent was designed to obtain reagent related fragmentation of the whole reagent as well as a side group of the reagent. Collision energies for detection of alkylating components derivatized using the new reagent are shown to be significantly more universal than with 4-DMAP. Neutral loss scanning on the fragmentation related to the build in side group remedies shortcomings in the screening for alkyl halides observed when using 4-DMAP. The new approach allows for screening of alkyl halides and alkyl sulfonates at trace levels down to 1 mg kg(-1) and target analysis at about a factor of 10 lower without a significant effect of the active pharmaceutical ingredient (API) matrix. The synthesis of the reagent, investigation of reactivity, the specificity of the fragmentation of derivatives and screening conditions in MS/MS analysis are described.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: 4-Aminopiridina / Espectrometría de Masas en Tándem / Mutágenos Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: J Pharm Biomed Anal Año: 2013 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: 4-Aminopiridina / Espectrometría de Masas en Tándem / Mutágenos Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: J Pharm Biomed Anal Año: 2013 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido